Download Cervical Cancer - v4.0

Download Cervical Cancer - v4.0
Package Name com.newandromo.dev338923.app609995
Category ,
Latest Version 4.0
Get it On Google Play
Update November 19, 2020 (4 years ago)

You've heard of Cervical Cancer - v4.0, or Medical PG, FMGE Preparation - PrepLadder, Pacify, Dexcom G6, X-RAY WOW, Inject App, ALAT, one of the coolest APPS of the genre Medical.

And of course you know that, not all games or applications are compatible for all phones. The game or application is sometimes not available on your device, it depends on the version of the system. Android operating system, screen resolution, or countries that Google Play allows access to.That is why APKPanda provides Android APK files for you to download and doesn't stick to these restrictions. >
Cervical Cancer - v4.0 latest version is 4.0, release date 2020-11-19, and has size 3.5 MB.Developed by Fumo, Cervical Cancer - v4.0 requires Android version at least Android 4.1+. Therefore you must update your phone if necessary.

Pretty much loaded, about 1000 downloads. You can update apps that have been downloaded or installed individually on your Android device if you want. Updating your apps gives you permission access to the latest features and improve application security and stability.

Cervical Cancer - v4.0

Cervical cancer is the third most common malignancy in women worldwide, and it remains a leading cause of cancer-related death for women in developing countries. In the United States, cervical cancer is relatively uncommon.
The incidence of invasive cervical cancer has declined steadily in the United States over the past few decades; however, it remains at high levels in many developing countries. The change in the epidemiologic trend in the United States has been attributed to mass screening with Papanicolaou (Pap) tests, which permits detection and treatment of preinvasive disease.
Recognition of the etiologic role of human papillomavirus (HPV) infection in cervical cancer has led to the recommendation of adding HPV testing to the screening regimen in women 30-65 years of age. However, women who have symptoms, abnormal screening test results, or a gross lesion of the cervix are best evaluated with colposcopy and biopsy.

Show more